Retraction of:
HOXD-AS1 Exerts Oncogenic Functions and Promotes Chemoresistance in Cisplatin-Resistant Cervical Cancer Cells by Chi et al. (doi: 10.1089/hum.2017.256)
Hum Gene Ther
.
2022 May;33(9-10):572.
doi: 10.1089/hum.2017.256.retract.
Epub 2022 Mar 28.
PMID:
35353631
PMCID:
PMC9142764
DOI:
10.1089/hum.2017.256.retract
No abstract available
Publication types
Retraction Notice